
|Videos|February 13, 2013
Introduction: Advances and Issues in NSCLC
Advertisement
For High-Definition, Click
In the first installment of the series, the moderator, David R. Gandara, MD, provides an overview of the topics that will be discussed by the panel, which includes: Corey J. Langer, MD, Alan B. Sandler, MD, Mark A. Socinski, MD, and Anne S. Tsao, MD.
Gandara notes that this Peer Exchange discussion will focus on a range of issues and challanges facing physicians who treat patients with lung cancer. Specifically, the panel will examine new therapies and testing for molecular abnormalities and the integration of these test results into the treatment decision making process.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on OncLive
1
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
2
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
3
PD-L1 Expression Is More Predictive of Response to Pembrolizumab on Metastatic Sites in High-Grade Serous Ovarian Cancer
4
Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies
5



































